Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2020 | 1 |
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Reconstituted HDL-apoE3 promotes endothelial cell migration through ID1 and its downstream kinases ERK1/2, AKT and p38 MAPK.
Metabolism. 2022 Feb;127:154954. doi: 10.1016/j.metabol.2021.154954. Epub 2021 Dec 4.
Metabolism. 2022.
PMID: 34875308
Advances in biological therapies for dyslipidemias and atherosclerosis.
Valanti EK, Dalakoura-Karagkouni K, Siasos G, Kardassis D, Eliopoulos AG, Sanoudou D.
Valanti EK, et al.
Metabolism. 2021 Mar;116:154461. doi: 10.1016/j.metabol.2020.154461. Epub 2020 Dec 5.
Metabolism. 2021.
PMID: 33290761
Review.
Item in Clipboard
The future of apolipoprotein E mimetic peptides in the prevention of cardiovascular disease.
Valanti EK, Chroni A, Sanoudou D.
Valanti EK, et al.
Curr Opin Lipidol. 2019 Aug;30(4):326-341. doi: 10.1097/MOL.0000000000000615.
Curr Opin Lipidol. 2019.
PMID: 31157629
Review.
Item in Clipboard
Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis.
Valanti EK, Dalakoura-Karagkouni K, Sanoudou D.
Valanti EK, et al.
J Pers Med. 2018 Oct 3;8(4):34. doi: 10.3390/jpm8040034.
J Pers Med. 2018.
PMID: 30282955
Free PMC article.
Review.
Item in Clipboard
Cite
Cite